Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
10,154
archived clinical trials in
Other Indications

Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Maryland
mi
from
Baltimore, MD
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Maryland
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Hudson Valley Hematology and Oncology Associates
mi
from
Hawthorne, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Hudson Valley Hematology and Oncology Associates
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Westchester Oncology Hematology Group, P.C.
mi
from
Hawthorne, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Westchester Oncology Hematology Group, P.C.
mi
from
Hawthorne, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
New York Presbyterian Hospital (Cornell)
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
New York-Presbyterian Hospital
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
New York-Presbyterian Hospital
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Weill Cornell Medical Center
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Weill Cornell Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Weill-Cornell Medical College
mi
from
New York, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Rochester Cancer Center Pharmacy
mi
from
Rochester, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Rochester Cancer Center Pharmacy
mi
from
Rochester, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
University of Rochester Medical Center Strong Memorial Hospital - James P. Wilmot Cancer Center
mi
from
Rochester, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
University of Rochester Medical Center Strong Memorial Hospital - James P. Wilmot Cancer Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Westchester Medical Center
mi
from
Valhalla, NY
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Westchester Medical Center
mi
from
Valhalla, NY
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Penn State Milton S. Hershey Medical Center
mi
from
Hershey, PA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
The University Of Texas
mi
from
Houston, TX
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
The University Of Texas
mi
from
Houston, TX
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Virginia Commonwealth University Massey Cancer Center
mi
from
Richmond, VA
Click here to add this to my saved trials
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated:  10/27/2015
Hospital Universitario Austral
mi
from
Derqui-Pilar,
Study Evaluating SKI-606 (Bosutinib) In Philadelphia Chromosome Positive Leukemias
A Phase 1/2 Study Of Bosutinib (SKI-606) In Philadelphia Chromosome Positive Leukemias
Status: Enrolling
Updated: 10/27/2015
Hospital Universitario Austral
mi
from
Derqui-Pilar,
Click here to add this to my saved trials
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated:  10/29/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated: 10/29/2015
Mayo Clinic Arizona
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated:  10/29/2015
The Mayo Clinic
mi
from
Rochester, MN
Nilotinib and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Blastic Phase Chronic Myelogenous Leukemia
A Phase II Study of Combination Nilotinib and Hyper-CVAD in Patients Newly Diagnosed With Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia Blast-Phase Lymphoid Lineage
Status: Enrolling
Updated: 10/29/2015
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
UC Davis MIND Institute
mi
from
Sacramento, CA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
UC Davis MIND Institute
mi
from
Sacramento, CA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Childrens Hospital Colorado
mi
from
Denver, CO
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Childrens Hospital Colorado
mi
from
Denver, CO
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Children's National Hospital
mi
from
Washington,
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Children's National Hospital
mi
from
Washington,
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Rush University Medical Center
mi
from
Chicago, IL
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Kennedy Krieger Institute
mi
from
Baltimore, MD
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Univ of Massachusetts Med School
mi
from
Worcester, MA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Univ of Massachusetts Med School
mi
from
Worcester, MA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
University of Michigan
mi
from
Ann Arbor, MI
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
University of Nebraska
mi
from
Omaha, NE
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
University of Nebraska
mi
from
Omaha, NE
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Cincinnati Children's Hospital Medical Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Autism & Developmental Medicine Institute Geisinger Health System
mi
from
Lewisburg, PA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Autism & Developmental Medicine Institute Geisinger Health System
mi
from
Lewisburg, PA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Suburban Research Associates
mi
from
Media, PA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Suburban Research Associates
mi
from
Media, PA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Greenwood Genetic Center
mi
from
Greenwood, SC
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Greenwood Genetic Center
mi
from
Greenwood, SC
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Texas Children's Hospital
mi
from
Houston, TX
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Texas Children's Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Seattle Children's Hospital
mi
from
Seattle, WA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Emory University
mi
from
Atlanta, GA
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated:  10/29/2015
Mount Sinai School of Medicine
mi
from
New York, NY
A Safety Study of NNZ-2566 in Patients With Fragile X Syndrome
A Phase II Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dose Study of NNZ-2566 in Fragile X Syndrome
Status: Enrolling
Updated: 10/29/2015
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis
A Prospective Trial Comparing the Response to Hyperbaric Oxygen Treatment in Patients With Ulcerative and Non-Ulcerative Interstitial Cystitis
Status: Enrolling
Updated:  11/1/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Prospective Trial Comparing Response to Hyperbaric Oxygen Treatment in Patients With Interstitial Cystitis
A Prospective Trial Comparing the Response to Hyperbaric Oxygen Treatment in Patients With Ulcerative and Non-Ulcerative Interstitial Cystitis
Status: Enrolling
Updated: 11/1/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Status: Enrolling
Updated:  11/1/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Intravesical Liposomes for Interstitial Cystitis/Painful Bladder Syndrome (IC/PBS)
Status: Enrolling
Updated: 11/1/2015
William Beaumont Hospital
mi
from
Royal Oak, MI
Click here to add this to my saved trials
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer: A Pilot Study
Status: Enrolling
Updated:  11/2/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer
Nasal Saline Irrigation After Radiation Therapy for Oropharyngeal Cancer: A Pilot Study
Status: Enrolling
Updated: 11/2/2015
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Center For Clinical Research Inc.
mi
from
San Francisco, CA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
University of Miami School Hospital
mi
from
Miami, FL
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
University of Miami School Hospital
mi
from
Miami, FL
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Tufts Medical Center
mi
from
Boston, MA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Englewood Hospital and Medical Center
mi
from
Englewood, NJ
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
St. Luke's Roosevelt Hospital Center
mi
from
New York City, NY
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
St. Luke's Roosevelt Hospital Center
mi
from
New York City, NY
Click here to add this to my saved trials
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated:  11/2/2015
Boston Med Ctr
mi
from
Boston, MA
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients With Venous Leg Ulcers
Status: Enrolling
Updated: 11/2/2015
Boston Med Ctr
mi
from
Boston, MA
Click here to add this to my saved trials
Augmentation Cystoplasty Using an Autologous Neo-Bladder
An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida
Status: Enrolling
Updated:  11/2/2015
Boston Children's Hospital
mi
from
Boston, MA
Augmentation Cystoplasty Using an Autologous Neo-Bladder
An Open-Label Multicenter Study of Augmentation Cystoplasty Using an Autologous Neo-Bladder Construct in Subjects With Spina Bifida
Status: Enrolling
Updated: 11/2/2015
Boston Children's Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated:  11/4/2015
Clinical Research Facility
mi
from
Rochester, MN
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated: 11/4/2015
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated:  11/4/2015
Clinical Research Facility
mi
from
Houston, TX
Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome
Open-Label, Dose-Escalating, Clinical and Pharmacokinetic Phase I Study of Lurbinectedin (PM01183) in Patients With Advanced Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome.
Status: Enrolling
Updated: 11/4/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers: a Double-blind, Randomized,Controlled Clinical Trial.
Status: Enrolling
Updated:  11/5/2015
David Grant USAF Medical Center
mi
from
Travis AFB, CA
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers
Hyperbaric Oxygen for Wagner II Diabetic Lower Extremity Ulcers: a Double-blind, Randomized,Controlled Clinical Trial.
Status: Enrolling
Updated: 11/5/2015
David Grant USAF Medical Center
mi
from
Travis AFB, CA
Click here to add this to my saved trials
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated:  11/6/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated: 11/6/2015
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated:  11/6/2015
Children's Hospital Oakland
mi
from
Oakland, CA
Genetic and Physical Characteristics of Rett Syndrome
Rett Syndrome Natural History: Genetic and Physical Characteristics of Rett Syndrome
Status: Enrolling
Updated: 11/6/2015
Children's Hospital Oakland
mi
from
Oakland, CA
Click here to add this to my saved trials